Bioventus
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $147,660 | $123,876 | $153,642 | $138,964 |
Gross Profit | 102,090 | 83,056 | 102,656 | 93,551 |
EBITDA | 29,856 | 15,957 | 21,634 | 16,975 |
EBIT | 17,807 | 4,092 | 9,229 | 4,700 |
Net Income | 7,459 | -2,637 | -156 | -4,824 |
Net Change In Cash | 147,660 | 123,876 | 153,642 | 138,964 |
Free Cash Flow | 25,255 | -20,157 | 18,748 | 10,252 |
Cash | 32,910 | 22,802 | 41,582 | 43,074 |
Basic Shares | 68,536 | 66,008 | 65,451 | 65,258 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $573,280 | $512,345 | $512,117 | $430,898 |
Gross Profit | 388,226 | 328,193 | 331,080 | 302,706 |
EBITDA | -49,555 | -23,070 | -121,606 | 45,475 |
EBIT | -99,110 | -80,435 | -177,004 | 6,791 |
Net Income | -33,542 | -156,230 | -158,704 | 19,375 |
Net Change In Cash | 573,280 | 512,345 | 512,117 | 430,898 |
Cost of Revenue | 12,602 | |||
Free Cash Flow | 37,789 | 7,982 | -25,057 | 15,621 |
Cash | 41,582 | 36,964 | 30,186 | 43,933 |
Basic Shares | 65,355 | 62,647 | 61,389 | 45,472 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.21 |
2025-03-31 | -$0.03 |
2024-12-31 | $0.15 |
